Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Study Locations section was updated: new sites were added across several U.S. states and international locations (e.g., Alabama, Arkansas, California, Colorado, Florida, Missouri, Ohio, Tennessee, Texas, Virginia, Tel Aviv, Chiba, Tokyo, Gyeonggido, Seoul Teugbyeolsi), and several existing sites were removed.
    Difference
    2%
    Check dated 2025-12-23T12:46:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A minor revision update indicates version v3.3.2 was published; no changes to core study content, eligibility, outcomes, or locations are evident in the visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:51:05.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:52:08.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Added Tainan, Taiwan, 704 to the Locations section. Replaced the listing 'Tainan City, Taiwan, 704' with 'Tainan, Taiwan, 704' to reflect corrected locality naming.
    Difference
    0.4%
    Check dated 2025-11-17T07:15:32.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    No substantive content changes detected on the Study Details page; updates appear to be UI/formatting adjustments without changes to core sections such as eligibility criteria or outcome measures — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:19.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center (high importance). - Updated version to v3.2.0; removed v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-05T10:12:26.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.